Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Coronavirus LIVE: Applying for emergency vaccine use soon, says Serum CEO arrow Farmer protest LIVE: Government is ready to hold talks, says Amit Shah arrow PM Modi tours 3 cities, takes stock of coronavirus vaccine development arrow Sebi bars NDTV promoters, others in insider trading case; company to appeal arrow Volunteer for Oxford's Covid-19 vaccine seeks Rs 5 crore compensation arrow EPFO extends deadline to submit life certificate by pensioners till Feb 28 arrow Centre's ethanol push prompts sugar mills to increase production arrow Rising FDI shows investors prefer India's enabling environment: Goyal arrow Baba Ramdev on board of Ruchi Soya; brother Ram Bharat to be MD arrow PM visit will motivate us to 'bridge unmet healthcare needs': Zydus Cadila arrow GDP data: Contraction can be ignored, but pre-Covid declining trend irksome arrow Govt 'cautiously optimistic' as GDP contraction not so sharp in Q2: CEA arrow Max Financial gets Irdai nod for share swap agreement with Mitsui Sumitomo arrow DATA STORY: After 3 days, India's active Covid cases see net decline, down 615 arrow Apr-Sep FDI inflow climbs 15% to Rs 2.2 trillion; Mauritius was top source arrow World Coronavirus Dispatch: Recovery warrants wrestling with human nature arrow Uber, Ola surge price capped; 10-hour break must for taxi drivers arrow Lab to clinic: The genesis of coronavirus vaccine conversation in India arrow Facebook crypto Libra to launch as early as Jan but scaled back: Report arrow Farm sector maintains robust growth in Q2, GVA up 7.7% at current prices arrow Speed of economic recovery a 'pleasant surprise': Niti Aayog's Rajiv Kumar arrow RBI issues another marquee 10-year bond, making it third this calendar arrow Introspect reasons for low market valuation: DIPAM secy to state-owned cos arrow Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India

BIOCON LTD. 429.35 3.60 (0.85%)

  • BSE: 532523
  • |
  • |
  • ISIN NO: INE376G01013
  • |
  • INDUSTRY: Biotechnology


Biocon Limited or BIOCON

Biocon, which is Asia's largest biotechnology company, started itself with a seed capital of INR 10, 000 in the year 1978, and currently, it is a billion dollar company. It also manufactures the biotechnological products catering to the healthcare section and engages itself in all the phases of the product cycle from discovering to development & then commercializing the same drugs. It consists of a fermentation-based technology which is creating cost-effec ... tive, and some of its subsidiaries are Syngene and Clinigene for the international pharmaceutical and biotechnology majors. Biocon produces antidiabetic agents like Acarbose, Pioglitazone, and Repaglinide & Rosiglitazone. In the biological section, it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), and Streptokinase & Monoclonal Antibodies. The drug major provides mycophenolate mofetil, tacrolimus, and sirolimus. It also produces and market mix of specialty & industrial enzymes for industries such as brewing, paper, beverages, food, brewing, textiles & distilling. The company's drug portfolio also consists of lovastatin, simvastatin, pravastatin, and atorvastatin.

The Business of the Company:

It has a fully integrated business model that spans the entire drug value chain, from the preclinical discovery to clinical development and through to commercialization. Its businesses are spread in various custom research (Syngene), clinical development (Clinigene) and biopharmaceuticals (Biocon) which provides multiple revenue streams to balance risk, drive innovation, deliver products, and accelerates the growth. As the company has increased both the complexity as well as the scope of its R&D and manufacturing operations, especially in the case of new product discovery and development, it is believed that the custom, as well as clinical research services, will continue to offer such essential synergies.


The Milestones:

Some Awards:

Read More
Key Data
  • Market cap 54061.00 CR.
  • Book value 62.81
  • Stock P/E 146
  • Dividend Yield 0.11%
  • ROCE 5.30%
  • ROE 4.16%
  • Sales Growth (3Y) -8.41%
  • Face Value (3Y) 5.00
Trend Analysis
  • Short Term Trend :
  • Medium Term Trend :
    Not Clear
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.


What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
10 AM - -
11 AM - -
12 PM - -
1 PM - -
2 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Higher High Higher Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 395.02 404.67 414.32 420.03 423.97 429.68 433.62 443.27 452.92
woodie's 398.32 407.97 413.11 417.62 422.76 427.28 432.41 436.92 446.58
fibonacci - 414.32 418.00 420.28 423.97 427.65 429.93 433.62 -
camarilla 420.44 423.10 423.98 424.87 -- 426.63 427.52 428.40 431.06
Past Performance & Moving Averages
10 DAY 415.00
425.64 0.67 % 1.48 %
20 DAY 395.60
418.62 3.01 % 5.01 %
50 DAY 389.75
430.16 -5.63 % 10.14 %
100 DAY 372.25
420.50 7.92 % 13.98 %
200 DAY 235.55
379.42 21.63 % 40.86 %
YTD 235.55
368.25 46.03 % 6.75 %
52 Week 211.05
324.30 55.47 % 7.33 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Up On 2020-04-07
297.30 ~ 295.85 SUPPORT
Unfilled Gap Down On 2019-06-12
271.35 ~ 525.50 RESISTANCE
Unfilled Gap Down On 2017-06-15
346.00 ~ 1014.00 RESISTANCE
Industry Growth Rate

In Last 1 Year the industry has grown by 26.58 %

In Last 5 Year the industry has grown by 11.92 %

Peer comparison


COMPANY NAME 2014 2015 2016 2017 2018 2019
BIOCON 2877.00 3090.00 3347.00 3891.00 4123.00 5514.00
PANACEABIO 510.00 687.00 653.00 544.00 593.00 457.00
ALPA 56.39 57.25 53.46 63.45 62.13 76.96
Total 1147.80 1278.08 1351.15 1499.48 1592.71 2015.99


1 PANACEA BIOTEC LTD. 92441.23 150.40 58.36 6.16 21.40 6.33 457.00 38.00 8.32%
2 BIOCON LTD. 51522.00 429.35 60.95 7.54 39.16 3.02 19.63% 5514.00 905.00 16.41% 33.74% 143.28% 13.11% 25.55%
3 ALPA LABORATORIES LTD. 3892.69 18.50 51.66 0.38 53.82 0.04 1.63% 76.96 0.79 1.03% 23.87%

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.


What is Profit & EPS Trend ?

EPS Trends was initially built in late 2015 when I was just getting into frontend development. Coming from a background in Rails, I was frustrated with how many decisions you had to make early on as a javascript developer.

Net Profit

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBIT Margin
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 4.17
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 7.90
    Safe (2.6 & above)

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

BIOCON: Future
BIOCON20DECFUT 12045100.00 9243700.00 426.50 2300 2020-12-31
BIOCON21JANFUT 87400.00 87400.00 426.65 2300 2021-01-28
BIOCON21FEBFUT 4600.00 6900.00 433.85 2300 2021-02-25
ROLLOVER COST: 0.04% (INR 0.15)
What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Ratio Analysis

The Bank was incorporated in the year 2004 by Rana Kapoor and Late Ashok Kapur, which is a new age private sector bank. And since the inception of the bank has fructified into a “Full-Service Commercial Bank,” it has steadily built Corporate and Institutional Banking, Financial Markets, Investment Banking, Corporate Finance, Branch Banking, Business and Transaction Banking, and Wealth Management business lines across the whole country.

It is well-equipped to offer a spectrum of products and services to all the corporate and retail customers.

Read More
Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
BIOCON 2007-10-09 JF ASSET MANAGEMENT LIMITED S 650000.00 483.28
BIOCON 2006-01-27 FIDILITY FID FUND P 1351807.00 470.00
BIOCON 2006-01-27 GLENTEC INTERNATIONAL S 2298800.00 470.00
BIOCON 2005-12-28 GLENTEC INTERNATIONAL S 1432403.00 491.85
BIOCON 2005-12-28 THE MASTER TRUST BANKER J P 680250.00 491.85
BIOCON 2005-03-30 ANIL KUMAR AGARWAL P 31822.00 403.75
BIOCON 2005-03-30 ANUBHAV AGARWAL S 31822.00 403.75
BIOCON 2004-04-13 AOF HS Mauritius Ltd. S 2000000.00 608.53
BIOCON 2004-04-13 AOF HS Mauritius Ltd. S 2830000.00 605.70
BIOCON 2004-04-13 Emerging Markets MGT.LLC/ P 367060.00 605.00
BIOCON 2004-04-13 Emerging Markets MGT.LLC/ P 383440.00 605.00
BIOCON 2004-04-13 Goldman Sachs Invst. Maur P 386560.00 605.00
BIOCON 2004-04-13 Goldman Sachs Invst. Maur P 3080000.00 605.00
BIOCON 2004-04-13 HSBC Equity Fund P 300000.00 605.00
BIOCON 2004-04-13 HSBC India Opportunities P 150000.00 605.00
BIOCON 2004-04-13 Mahesh Kumar Damani P 367062.00 666.68
BIOCON 2004-04-13 Mahesh Kumar Damani S 367062.00 658.85
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
BIOCON 2016-02-23 NEW INDIA INVESTMENT TRUST PLC P 240000.00 471.35
Dividend history
Ex Date Amount
2019-07-18 0.50
2018-07-19 1.00
2017-07-20 1.00
2016-03-17 5.00
2015-04-09 5.00
2014-07-10 5.00
2013-07-11 5.00
2013-07-11 2.50
2012-07-05 5.00
2011-07-07 3.00
2011-05-05 1.50
2010-07-08 3.50
2009-07-08 3.00
2008-07-03 5.00
Bonus Data
Company Name Split Date From Value To Value
BIOCON LTD. 2019-06-12 1.00 1.00
BIOCON LTD. 2017-06-15 2.00 1.00
BIOCON LTD. 2008-09-11 1.00 1.00
Split Data
Company Name Split Date From Value To Value